The Gillett Health Podcast

Kyle Gillett and James O'Hara

Health Optimization

  1. Bioidentical V.S. Non-Bioidentical Hormones

    JAN 2

    Bioidentical V.S. Non-Bioidentical Hormones

    James O'Hara sits down with Dr Dan Bristow (OB-GYN) to talk about hormones For High-quality labs: ► http://sagebio.com/ For information on the Gillett Health clinic, lab panels, and health coaching: ► https://GillettHealth.com Follow Gillett Health for more content from James and Kyle ► https://instagram.com/gilletthealth ► https://www.tiktok.com/@gilletthealth ► https://twitter.com/gilletthealth ► https://www.facebook.com/gilletthealth Follow Kyle Gillett, MD ► https://instagram.com/kylegillettmd Follow James O’Hara, NP ► https://Instagram.com/jamesoharanp For 10% off Gorilla Mind products, including SIGMA: Use code “GH10” ► https://gorillamind.com/ For discounts on high-quality supplements ►https://www.thorne.com/u/GillettHealth ►Compiled Source List Systematic and Narrative Reviews 1. Gut microbial β‑glucuronidase: a vital regulator in female estrogen metabolism and gynecologic cancers PMCID: PMC10416750 • Year: 2023 • Journal: International Journal of Molecular Sciences • Summary: Reviews role of β-glucuronidase in estrogen metabolism, breast cancer, endometriosis. 2. A New Paradigm in Gut Microbiota & Breast Cancer: β‑Glucuronidase as Therapeutic Target DOI: 10.3390/pathogens12091086 • Year: 2023 • Journal: Pathogens • Summary: Emerging model proposing gmGUS as a direct target in estrogen-driven breast cancer. 3. Gut and oral microbiota in gynecologic cancers: mechanisms and therapeutic value DOI: 10.1038/s41522-024-00577-7 • Year: 2024 • Journal: npj Biofilms and Microbiomes • Summary: Systematic review on microbiota’s role in ovarian, cervical, and breast cancers. Human Clinical or Case-Control Studies 4. Assessment of gut microbial β‑glucuronidase and β‑glucosidase activity in women with PCOS PMCID: PMC10366212 • Year: 2023 • Journal: Scientific Reports • Summary: Found significantly higher β-glucuronidase activity in PCOS patients. 5. Gut microbiota and ovarian diseases: a new therapeutic perspective DOI: 10.1186/s13048-025-01684-5 • Year: 2025 • Journal: Journal of Ovarian Research • Summary: Review covering PCOS, POI, and tumors—describes estrogen recycling via gut microbiota. Mechanistic, In Vitro, and Animal Studies 6. In vitro analysis of gut microbial β‑glucuronidases and estrogen deconjugation DOI: 10.1016/j.jbc.2020.105542 • Year: 2020 • Journal: Journal of Biological Chemistry • Summary: Characterized 35 GUS enzymes that reactivate estrogen glucuronides. 7. Impact of intestinal flora on ovarian function and disease pathogenesis Full text: e-century.us • Year: 2024 • Journal: American Journal of Translational Research • Summary: Animal studies showing how β-G-producing gut bacteria drive ovarian dysfunction. 8. The role of gut microbiota in endometriosis: current insights DOI: 10.3389/fmicb.2024.1363455 • Year: 2024 • Journal: Frontiers in Microbiology • Summary: Mechanistic review linking β-G-producing bacteria to lesion development and inflammation in endometriosis. #female #femalehealth #hormones #testosterone Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy

    50 min
4.6
out of 5
61 Ratings

About

Health Optimization

You Might Also Like